April, 2018

  • 20 April

    Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

    RENSSELAER, N.Y., April 20, 2018 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska. Easi–CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of […]

    Read More »
  • 20 April

    PayByPhone appoints Andreas Gruber as new President and CEO

    VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) — PayByPhone, the global leader in mobile parking payments, today announced that it will appoint Andreas Gruber as president and Chief Executive Officer effective June 1st, 2018. Francis Dupuis, the former President and CEO, will take over a position in Germany with parent company Volkswagen Financial Services […]

    Read More »
  • 20 April

    Progress and Potential for Achieving Cleaner Air on a Global Basis

    Adoption of New Generation Diesel Technology Delivers Rapid Clean Air Benefits New understanding of global air quality highlights the need for technologies like new-generation diesel engines, which are capable of accelerating emissions reductions WASHINGTON, April 19, 2018 (GLOBE NEWSWIRE) — Recent reports highlighting air quality conditions in the United States (State of the Air) and […]

    Read More »
  • 19 April

    SpeeDx receives FDA clearance for Mycoplasma genitalium product

    SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) — SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company’s recently incorporated US entity, SpeeDx Inc. The announcement coincides with the FDA registration of the Australian parent company – SpeeDx […]

    Read More »
  • 19 April

    Taconic Biosciences Launches New Inflammatory Bowel Disease Models

    RENSSELAER, N.Y., April 19, 2018 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous […]

    Read More »